{"DataElement":{"publicId":"5544985","version":"1","preferredName":"Eligible Diagnosis Present Disease or Disorder Type","preferredDefinition":"A description of the eligible diagnosed disease or disorder that was present.","longName":"5544984v1.0:5589155v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5544984","version":"1","preferredName":"Eligible Diagnosis Present","preferredDefinition":"Satisfying the appropriate conditions for inclusion._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Being or existing in a specified place or at the specified time.","longName":"5544982v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5544982","version":"1","preferredName":"Eligible Diagnosis","preferredDefinition":"Satisfying the appropriate conditions for inclusion.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C126586:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eligible","conceptCode":"C126586","definition":"Satisfying the appropriate conditions for inclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDC2EC9-FB75-65C8-E053-F662850A561D","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDC2EC9-FB83-65C8-E053-F662850A561D","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5589155","version":"1","preferredName":"Diagnosed Disease or Disorder Type","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Something distinguishable as an identifiable class based on common qualities.","longName":"5589155v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Post-essential thrombocythemia myelofibrosis","valueDescription":"Myelofibrosis Transformation in Essential Thrombocythemia","ValueMeaning":{"publicId":"5589179","version":"1","preferredName":"Myelofibrosis Transformation in Essential Thrombocythemia","longName":"5589179","preferredDefinition":"Myelofibrosis that develops in a patient with history of essential thrombocythemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post-Essential Thrombocythemia Myelofibrosis","conceptCode":"C126806","definition":"Myelofibrosis that develops in a patient with history of essential thrombocythemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB656D-405C-53A3-E053-F662850A238D","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EB656D-4075-53A3-E053-F662850A238D","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Post-polycythemia vera myelofibrosis","valueDescription":"Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase","ValueMeaning":{"publicId":"5589177","version":"1","preferredName":"Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase","longName":"5589177","preferredDefinition":"Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow, leucoerythroblastic reaction in the peripheral blood, poikilocytosis, tear-drop shaped red blood cells, and splenomegaly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase","conceptCode":"C41233","definition":"Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow, leucoerythroblastic reaction in the peripheral blood, poikilocytosis, tear-drop shaped red blood cells, and splenomegaly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB656D-4036-53A3-E053-F662850A238D","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EB656D-404F-53A3-E053-F662850A238D","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Primary myelofibrosis","valueDescription":"Primary Myelofibrosis","ValueMeaning":{"publicId":"5589180","version":"1","preferredName":"Primary Myelofibrosis","longName":"5589180","preferredDefinition":"A chronic myeloproliferative neoplasm characterized by bone marrow fibrosis, proliferation of atypical megakaryocytes and granulocytes in the bone marrow, anemia, splenomegaly, and extramedullary hematopoiesis. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Myelofibrosis","conceptCode":"C2862","definition":"A chronic myeloproliferative neoplasm characterized by bone marrow fibrosis, proliferation of atypical megakaryocytes and granulocytes in the bone marrow, anemia, splenomegaly, and extramedullary hematopoiesis. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB656D-407F-53A3-E053-F662850A238D","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EB656D-4098-53A3-E053-F662850A238D","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Hb S beta + thalassemia","valueDescription":"Sickle Beta Plus Thalassemia","ValueMeaning":{"publicId":"3301974","version":"1","preferredName":"Sickle Beta Plus Thalassemia","longName":"3301974","preferredDefinition":"A mild form of sickle cell thalassemia characterized by the presence of hemoglobin S and a small amount of hemoglobin A in the red blood cells. It is characterized by the presence of small red blood cells and mild anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Beta Plus Thalassemia","conceptCode":"C98837","definition":"A mild form of sickle cell thalassemia characterized by the presence of hemoglobin S and a small amount of hemoglobin A in the red blood cells. It is characterized by the presence of small red blood cells and mild anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DF96-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"53FBE360-BAFA-72D2-E053-F662850A43EA","beginDate":"2017-07-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-10","modifiedBy":"ONEDATA","dateModified":"2017-07-10","deletedIndicator":"No"},{"value":"Hb S beta 0 thalassemia","valueDescription":"Sickle Beta 0 Thalassemia","ValueMeaning":{"publicId":"3301975","version":"1","preferredName":"Sickle Beta 0 Thalassemia","longName":"3301975","preferredDefinition":"A form of sickle cell thalassemia characterized by the absence of hemoglobin A. Patients usually have severe anemia identical to that seen in sickle cell disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Beta 0 Thalassemia","conceptCode":"C98835","definition":"A form of sickle cell thalassemia characterized by the absence of hemoglobin A. Patients usually have severe anemia identical to that seen in sickle cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFBB-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"53FBE360-BB04-72D2-E053-F662850A43EA","beginDate":"2017-07-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-10","modifiedBy":"ONEDATA","dateModified":"2017-07-10","deletedIndicator":"No"},{"value":"Hb SC","valueDescription":"Hemoglobin SC Disease","ValueMeaning":{"publicId":"3298696","version":"1","preferredName":"Hemoglobin SC Disease","longName":"3298696","preferredDefinition":"One of the sickle cell disorders characterized by the presence of both hemoglobin S and hemoglobin C. It is similar to, but less severe than sickle cell anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell-Hemoglobin C Disease","conceptCode":"C34676","definition":"A hemoglobinopathy that is considered a hybrid of sickle cell disease and hemoglobin C disease. Patients present with the symptoms of sickle cell disease but the latter are less frequent and severe compared to sickle cell disease.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B09A8A1E-AE6D-F5AB-E040-BB89AD4305DF","latestVersionIndicator":"Yes","beginDate":"2011-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"53FC2D70-6945-69D0-E053-F662850A9B08","beginDate":"2017-07-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-10","modifiedBy":"ONEDATA","dateModified":"2017-07-10","deletedIndicator":"No"},{"value":"Hb SS","valueDescription":"Sickle Cell-SS Disease","ValueMeaning":{"publicId":"5899430","version":"1","preferredName":"Sickle Cell-SS Disease","longName":"5899430","preferredDefinition":"A variant of sickle cell disease due to homozygosity of the E6V mutation, amino acid substitution of valine for glutamic acid in the sixth position of the beta chain, resulting in the production of hemoglobin S from both alleles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell-SS Disease","conceptCode":"C131682","definition":"A variant of sickle cell disease due to homozygosity of the E6V mutation, amino acid substitution of valine for glutamic acid in the sixth position of the beta chain, resulting in the production of hemoglobin S from both alleles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53FC2D70-6952-69D0-E053-F662850A9B08","latestVersionIndicator":"Yes","beginDate":"2017-07-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"53FC2D70-696B-69D0-E053-F662850A9B08","beginDate":"2017-07-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-10","modifiedBy":"ONEDATA","dateModified":"2017-07-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5589154","version":"1","preferredName":"Diagnosis Disease or Disorder Type","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Something distinguishable as an identifiable class based on common qualities.","longName":"C15220:C2991:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB656D-3F08-53A3-E053-F662850A238D","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB656D-3F19-53A3-E053-F662850A238D","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"KUMMEROA","dateModified":"2017-07-10","changeDescription":". Added 4 PVs for 2558.  AK 7/10/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMSME_IC_eligib_diag_mye_tp","type":"NMDP_FN","context":"NHLBI"},{"name":"SCD_IC_eligib_diag_scd_tp","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Did the recipient have an eligible diagnosis?","type":"Alternate Question Text","description":"Did the recipient have an eligible diagnosis?","url":null,"context":"NHLBI"},{"name":"Did the recipient have an eligible diagnosis?","type":"Application Standard Question Text","description":"Did the recipient have an eligible diagnosis?","url":null,"context":"NHLBI"},{"name":"What was the eligible diagnos","type":"Preferred Question Text","description":"What was the eligible diagnosed disease or disorder that was present?","url":null,"context":"NHLBI"},{"name":"Specify the diagnosis","type":"Alternate Question Text","description":"Specify the diagnosis","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDC3D81-FA53-6556-E053-F662850A2341","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-27","modifiedBy":"NYCHM","dateModified":"2017-09-19","changeDescription":".Added AQT for form 2558r1  2017-07-12 SLS.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}